Reducing Urban Cervical Cancer Disparities

Description

This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.

Conditions

Cervical Cancer, Papilloma Viral Infection

Talk to us

Study Overview

On this page

Study Details

Study overview

This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.

Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance

Reducing Urban Cervical Cancer Disparities

Condition
Cervical Cancer
Intervention / Treatment

-

Contacts and Locations

New Brunswick

Rutgers, The State University of New Jersey, New Brunswick, New Jersey, United States, 08901

Philadelphia

Thomas Jefferson University, Philadelphia, Pennsylvania, United States, 19107

Philadelphia

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States, 19111

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
  • * referral for colposcopic evaluation at the clinic sites,
  • * able to communicate with ease in English,
  • * have a cell phone with texting ability, and
  • * competent to give consent.
  • * are pregnant at the time of recruitment,
  • * display current evidence or have a history of positive invasive carcinoma of the cervix, or
  • * require follow-up but not a colposcopy.

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Fox Chase Cancer Center,

Suzanne M Miller, PhD, PRINCIPAL_INVESTIGATOR, Fox Chase Cancer Center

Study Record Dates

2027-12